| Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy P Ricchi, R Zarrilli, A Di Palma, AM Acquaviva British journal of cancer 88 (6), 803-807, 2003 | 179 | 2003 |
| IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells A Di Popolo, A Memoli, A Apicella, C Tuccillo, A di Palma, P Ricchi, ... Oncogene 19 (48), 5517-5524, 2000 | 132 | 2000 |
| PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation V Leone, A di Palma, P Ricchi, F Acquaviva, M Giannouli, AM Di Prisco, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 293 (4 …, 2007 | 118 | 2007 |
| Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix S Pignata, G Silvestro, E Ferrari, L Selvaggi, F Perrone, A Maffeo, ... Journal of clinical oncology 17 (3), 756-756, 1999 | 99 | 1999 |
| Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry C Borgna‐Pignatti, MC Garani, GL Forni, MD Cappellini, E Cassinerio, ... British journal of haematology 167 (1), 121-126, 2014 | 96 | 2014 |
| Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco‐2 cells P Ricchi, S Pignata, A Di Popolo, A Memoli, A Apicella, R Zarrilli, ... International journal of cancer 73 (6), 880-884, 1997 | 87 | 1997 |
| Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or … A Pepe, A Meloni, G Rossi, L Cuccia, GD D'Ascola, M Santodirocco, ... Journal of Cardiovascular Magnetic Resonance 15 (1), 1, 2013 | 73 | 2013 |
| Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri S Pignata, P Frezza, S Tramontana, F Perrone, R Tambaro, G Casella, ... Annals of oncology 11 (4), 455-459, 2000 | 65 | 2000 |
| Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma S Pignata, B Daniele, MG Galati, G Esposito, P Vallone, F Fiore, P Ricchi, ... European journal of gastroenterology & hepatology 9 (3), 283-286, 1997 | 61 | 1997 |
| Using fuzzy logic for improving clinical daily-care of β-thalassemia patients S Santini, A Pescapè, AS Valente, V Abate, G Improta, M Triassi, P Ricchi, ... 2017 IEEE international conference on fuzzy systems (FUZZ-IEEE), 1-6, 2017 | 52 | 2017 |
| Aspirin protects Caco-2 cells from apoptosis after serum deprivation through the activation of a phosphatidylinositol 3-kinase/AKT/p21Cip/WAF1pathway P Ricchi, A Di Palma, T Di Matola, A Apicella, R Fortunato, R Zarrilli, ... Molecular pharmacology 64 (2), 407-414, 2003 | 41 | 2003 |
| Effect of splenectomy on iron balance in patients with β‐thalassemia major: a long‐term follow‐up M Casale, P Cinque, P Ricchi, S Costantini, A Spasiano, L Prossomariti, ... European Journal of Haematology 91 (1), 69-73, 2013 | 38 | 2013 |
| Involvement of Akt/NF‐κB pathway in N6‐isopentenyladenosine‐induced apoptosis in human breast cancer cells C Laezza, AM Malfitano, T Di Matola, P Ricchi, M Bifulco Molecular carcinogenesis 49 (10), 892-901, 2010 | 38 | 2010 |
| MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine A Pepe, A Meloni, L Pistoia, L Cuccia, MR Gamberini, R Lisi, DG D'Ascola, ... British Journal of Haematology 183 (5), 783-795, 2018 | 37 | 2018 |
| Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study P Ricchi, M Ammirabile, A Spasiano, S Costantini, P Cinque, T Di Matola, ... European journal of haematology 85 (1), 36-42, 2010 | 35 | 2010 |
| Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial AT Taher, MD Cappellini, A Kattamis, E Voskaridou, S Perrotta, AG Piga, ... The Lancet Haematology 9 (10), e733-e744, 2022 | 33 | 2022 |
| Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II R Russo, I Andolfo, F Manna, G De Rosa, L De Falco, A Gambale, ... Blood, The Journal of the American Society of Hematology 128 (14), 1899-1902, 2016 | 33 | 2016 |
| A useful relationship between the presence of extramedullary erythropoeisis and the level of the soluble form of the transferrin receptor in a large cohort of adult patients … P Ricchi, M Ammirabile, S Costantini, T Di Matola, R Verna, A Diano, ... Annals of hematology 91, 905-909, 2012 | 32 | 2012 |
| Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia KM Musallam, A Vitrano, A Meloni, SA Pollina, M Karimi, A El-Beshlawy, ... Haematologica 106 (9), 2489, 2021 | 31 | 2021 |
| Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients P Ricchi, M Ammirabile, A Spasiano, S Costantini, T Di Matola, P Cinque, ... European journal of haematology 82 (3), 219-222, 2009 | 30 | 2009 |
